3
Announcements
Trials
Browse
Landscape
Status
Completed
12
Unknown
3
Withdrawn
2
Recruiting
2
Active not recruiting
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
8
Observational
1
Sponsor
Conditions
Breast Neoplasms
138
Neoplasms
134
Lung Neoplasms
68
Prostatic Neoplasms
67
Carcinoma, Non-Small-Cell Lung
58
Colorectal Neoplasms
45
Multiple Myeloma
37
Pancreatic Neoplasms
33
Melanoma
32
Head and Neck Neoplasms
30
Brain Neoplasms
30
Neoplasm Metastasis
28
Ovarian Neoplasms
27
Liver Neoplasms
27
Carcinoma, Hepatocellular
27
Leukemia, Myeloid, Acute
25
Colonic Neoplasms
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Esophageal Neoplasms
20
Carcinoma, Renal Cell
20
Lymphoma, Non-Hodgkin
19
Urinary Bladder Neoplasms
18
Stomach Neoplasms
18
Glioblastoma
18
Uterine Cervical Neoplasms
17
Sarcoma
17
Lymphoma, Follicular
17
Lymphoma, Large B-Cell, Diffuse
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Observational
×
Peripheral Nervous System Diseases
×
Clear all
NCT04287075
2024-03-26
Rethink Pain
Axogen Corporation
Terminated
8 enrolled